INSP Inspire Medical Systems Inc

Price (delayed)

$246.85

Market cap

$7.17B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.6

Enterprise value

$6.74B

Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire's proprietary Inspire therapy is the ...

Highlights
The company's equity has surged by 117% YoY and by 5% QoQ
INSP's debt has shrunk by 78% YoY and by 4.4% QoQ
The company's quick ratio rose by 39% YoY but it fell by 13% QoQ
INSP's EPS is up by 12% since the previous quarter but it is down by 3.9% year-on-year
The company's gross margin fell by 2.2% YoY

Key stats

What are the main financial stats of INSP
Market
Shares outstanding
29.05M
Market cap
$7.17B
Enterprise value
$6.74B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
14.38
Price to sales (P/S)
16.99
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
16.52
Earnings
Revenue
$407.86M
EBIT
-$42.59M
EBITDA
-$39.69M
Free cash flow
$2.47M
Per share
EPS
-$1.6
Free cash flow per share
$0.09
Book value per share
$17.17
Revenue per share
$14.53
TBVPS
$20.12
Balance sheet
Total assets
$564.88M
Total liabilities
$68.87M
Debt
$7.54M
Equity
$496.01M
Working capital
$468.85M
Liquidity
Debt to equity
0.02
Current ratio
8.66
Quick ratio
8.38
Net debt/EBITDA
10.94
Margins
EBITDA margin
-9.7%
Gross margin
83.8%
Net margin
-11%
Operating margin
-11.7%
Efficiency
Return on assets
-10.7%
Return on equity
-12.7%
Return on invested capital
-56.1%
Return on capital employed
-8.5%
Return on sales
-10.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

INSP stock price

How has the Inspire Medical Systems stock price performed over time
Intraday
-2.7%
1 week
7.77%
1 month
-8.19%
1 year
5.94%
YTD
-2%
QTD
-2%

Financial performance

How have Inspire Medical Systems's revenue and profit performed over time
Revenue
$407.86M
Gross profit
$341.74M
Operating income
-$47.59M
Net income
-$44.88M
Gross margin
83.8%
Net margin
-11%
Inspire Medical Systems's revenue has soared by 75% YoY and by 17% from the previous quarter
The gross profit has soared by 71% YoY and by 17% from the previous quarter
INSP's net margin is up by 39% YoY and by 24% QoQ
The operating margin is up by 32% YoY and by 17% from the previous quarter

Growth

What is Inspire Medical Systems's growth rate over time

Valuation

What is Inspire Medical Systems stock price valuation
P/E
N/A
P/B
14.38
P/S
16.99
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
16.52
INSP's EPS is up by 12% since the previous quarter but it is down by 3.9% year-on-year
The company's equity has surged by 117% YoY and by 5% QoQ
The P/B is 27% below the last 4 quarters average of 19.7 and 11% below the 5-year quarterly average of 16.1
Inspire Medical Systems's revenue has soared by 75% YoY and by 17% from the previous quarter
The stock's P/S is 30% less than its 5-year quarterly average of 24.3 and 10% less than its last 4 quarters average of 18.8

Efficiency

How efficient is Inspire Medical Systems business performance
INSP's return on sales is up by 39% year-on-year and by 24% since the previous quarter
INSP's ROE is up by 32% year-on-year and by 27% since the previous quarter
INSP's ROA is up by 29% YoY and by 26% from the previous quarter
INSP's ROIC is down by 21% YoY but it is up by 10% from the previous quarter

Dividends

What is INSP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for INSP.

Financial health

How did Inspire Medical Systems financials performed over time
The company's total assets has surged by 91% YoY and by 7% QoQ
The company's quick ratio rose by 39% YoY but it fell by 13% QoQ
INSP's debt is 98% lower than its equity
The company's equity has surged by 117% YoY and by 5% QoQ
INSP's debt to equity has dropped by 87% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.